NervGen Pharma Corp. Common stock
- NGEN
- NASDAQ
- Biotechnology
- Neurodegenerative Disease Therapies
- Nerve Repair/Regeneration
$1.54
Today −3.14%Quote Oct 19, 2026, 08:00 PM UTC
−24.88%over the last month
Max drawdown −25.6%From 1-month high −25.6%3 months −13.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About NervGen Pharma Corp. Common stock
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
8
Founded
2017
Market value
$122.7M
Quote Oct 19
Analyst target
$12.00
+679.2% from here
Floor
$1.50
2.8% below price
Resistance
$1.64
6.7% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about NGENPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free